China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.88 -0.22 (-7.10%)
At close: Nov 10, 2026 · 4:00 PM EST

China SXT Pharmaceuticals (SXTC) Cash from Operations (2017 - 2019)

Updated

China SXT Pharmaceuticals (SXTC) recorded Cash from Operations of -$4.02 million in FY2026 (year ended Mar 31, 2026), compared with -$2.35 million in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Cash from Operations (2017 - 2019) Analysis & Trends

Starting with FY2017, China SXT Pharmaceuticals' Cash from Operations history includes 10 fiscal years.

  • The FY2026 figure is the lowest annual Cash from Operations in data going back to FY2017.
  • Per Business Quant data, SXTC's Cash from Operations was -$2.35 million in FY2025, -$1.93 million in FY2024, -$80,757 in FY2023 and $268,293 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 11.40 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 7.72 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 7.61 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.24 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 5.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.38 Bn
10 China SXT Pharmaceuticals 251.61 -85.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -1.21 Mn
Dec 31, 2018 1.92 Mn
Dec 31, 2017 293,042.00
API Access

China SXT Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=SXTC&period=max&api_key=YOUR_API_KEY